BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Ceftazidime

Ceftazidime Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients.

300+ PubMed studies analyzed · 40 RCTs · Evidence Score: 48.3

Research Domains

Ceftazidime has been studied across 9 research domains including 🫘 Kidney, 🫁 Respiratory, 🧠 Focus & Attention, 😴 Sleep, 🔬 Oncology. The primary research focus is 🫘 Kidney with 8% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ceftazidime, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Cefmenoxime
4 shared targets
Cefprozil
2 shared targets
Ceftibuten
2 shared targets
Cefpodoxime
2 shared targets
cefatrizine
2 shared targets
silver
2 shared targets
Cefoxitin
3 shared targets
Cephaloglycin
2 shared targets
Loteprednol
3 shared targets
Diflucortolone
2 shared targets
Loading evidence profile...

This evidence profile for Ceftazidime is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.